Abstract
There is a need for the study of complex diseases due to their important impact on our society. One of the solutions involves the theoretical methods which are fast and efficient tools that can lead to the discovery of new active drugs specially designed for these diseases. The Quantitative Structure - Activity Relationship models (QSAR) and the complex network theory become important solutions for screening and designing efficient pharmaceuticals by coding the chemical information of the molecules into molecular descriptors. This review presents the most recent studies on drug discovery and design using QSAR of several complex diseases in the fields of Neurology, Cardiology and Oncology.
Keywords: Drug design, QSAR, graphs, complex network, complex disease, QSAR Computational Methods, Drug Discovery, biochemical networks, drug-target interactions, protein-protein interaction networks, protein folding kinetics, (QPDRs), physio-chemical properties, Neurology, Cardiology, Oncology, QSAR models, TIs/CIs, information indices, MARCHINSIDE
Current Pharmaceutical Design
Title: Drug Discovery and Design for Complex Diseases through QSAR Computational Methods
Volume: 16 Issue: 24
Author(s): Cristian R. Munteanu, Enrique Fernandez-Blanco, Jose A. Seoane, Pilar Izquierdo-Novo, Jose Angel Rodriguez-Fernandez, Jose Maria Prieto-Gonzalez, Juan R. Rabunal and Alejandro Pazos
Affiliation:
Keywords: Drug design, QSAR, graphs, complex network, complex disease, QSAR Computational Methods, Drug Discovery, biochemical networks, drug-target interactions, protein-protein interaction networks, protein folding kinetics, (QPDRs), physio-chemical properties, Neurology, Cardiology, Oncology, QSAR models, TIs/CIs, information indices, MARCHINSIDE
Abstract: There is a need for the study of complex diseases due to their important impact on our society. One of the solutions involves the theoretical methods which are fast and efficient tools that can lead to the discovery of new active drugs specially designed for these diseases. The Quantitative Structure - Activity Relationship models (QSAR) and the complex network theory become important solutions for screening and designing efficient pharmaceuticals by coding the chemical information of the molecules into molecular descriptors. This review presents the most recent studies on drug discovery and design using QSAR of several complex diseases in the fields of Neurology, Cardiology and Oncology.
Export Options
About this article
Cite this article as:
R. Munteanu Cristian, Fernandez-Blanco Enrique, A. Seoane Jose, Izquierdo-Novo Pilar, Angel Rodriguez-Fernandez Jose, Maria Prieto-Gonzalez Jose, R. Rabunal Juan and Pazos Alejandro, Drug Discovery and Design for Complex Diseases through QSAR Computational Methods, Current Pharmaceutical Design 2010; 16 (24) . https://dx.doi.org/10.2174/138161210792389252
DOI https://dx.doi.org/10.2174/138161210792389252 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Therapeutic Approaches for the Management of Sleep Disorders in Geriatric Population
Current Medicinal Chemistry Pentraxins and Atherosclerosis: The Role of PTX3
Current Pharmaceutical Design Therapeutic efficacy of different iron chelators in Egyptian children with Beta Thalassemia with iron overload
Infectious Disorders - Drug Targets Pre-CKD- Do we Need Another Hero?
Current Vascular Pharmacology Vitamin D and Sepsis: From Associations to Causal Connections
Inflammation & Allergy - Drug Targets (Discontinued) The Role of Cnidaria in Drug Discovery. A Review on CNS Implications and New Perspectives
Recent Patents on CNS Drug Discovery (Discontinued) Flavonoids for Allergic Diseases: Present Evidence and Future Perspective
Current Pharmaceutical Design Induction of Cytoprotective Genes Through Nrf2 / Antioxidant Response Element Pathway: A New Therapeutic Approach for the Treatment of Inflammatory Diseases
Current Pharmaceutical Design Age-related Changes in Pharmacodynamics: Focus on Drugs Acting on Central Nervous and Cardiovascular Systems
Current Drug Metabolism Phenolics and Terpenoids; the Promising New Search for Anthelmintics: A Critical Review
Mini-Reviews in Medicinal Chemistry Postprandial Lipaemia, Haemostasis, Inflammatory Response and other Emerging Risk Factors for Cardiovascular Disease: The Influence of Fatty Meals
Current Nutrition & Food Science Azimilide, A Novel Oral Class III Antiarrhythmic for Both Supraventricular and Ventricular Arrhythmias
Current Drug Targets - Cardiovascular & Hematological Disorders Vitamin D Supplementation: A Promising Approach for the Prevention and Treatment of Strokes
Current Drug Targets Understanding the Concept of Chronotherapeutics in the Management of Diabetes Mellitus
Current Diabetes Reviews Amyloid A Amyloidosis Secondary to Rheumatoid Arthritis: An Uncommon Yet Important Complication
Current Rheumatology Reviews Homocysteine and Heart Failure: An Overview
Recent Patents on Cardiovascular Drug Discovery Immunophilins and Cardiovascular Complications
Current Medicinal Chemistry Gestational Programming of Offspring Obesity: A Potential Contributor to Alzheimers Disease
Current Alzheimer Research Targeting the Role of Lipoprotein (a) in Stroke
Cardiovascular & Hematological Disorders-Drug Targets The Co-Existence of NASH and Chronic Kidney Disease Boosts Cardiovascular Risk: Are there any Common Therapeutic Options?
Current Vascular Pharmacology